Lumida
/AXGN
⌘K
AxoGen Inc

AxoGen Inc

AXGN
$42.16USD+0.74%+0.31 today

MARKET CAP

2.3B

P/E (TTM)

FWD P/E

DAY RANGE

$40 – $43

52W RANGE

$15
$53

AI Summary

Stalk
StalkMedium

AXGN exhibited a terminal Capitulation (Final Flush) bar on extreme volume, signaling forced liquidation is ending and setting up a potential reflex rally within the long-term uptrend. Medium-term directional asymmetry shifts bullish given the terminal pattern, but price remains extended below the 9- and 21-day EMAs without evidence of stabilization. Execution should be deferred (Stalk) and focused on pullback absorption or early signs of a hold near intermediate moving averages before buying.

  • Q2 2026 revenue $69.7M (+23.1% YoY) reflects sustained sales momentum.
  • Breast procedure sales up 47% YoY show increased surgeon adoption.
  • Gross margin fell to 72.7% from 74.2% YoY due to higher production costs.
Full analysis →

Buying

7

institutions

Selling

5

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY4.42 M204.12 M+548.36 K+59.2%0.00%
CA

Citadel Advisors LLC

Q2 2026

BUY1.38 M63.64 M+1.12 M+653.5%0.01%
RI

Rtw Investments, LP

Q2 2026

BUYNEW1.01 M46.72 M+1.01 M+0.0%0.40%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL253.50 K11.71 M+-833.57 K-67.5%0.01%
PA

Perceptive Advisors LLC

Q2 2026

SELL247.31 K11.42 M+-1.15 M-75.3%0.17%
PA

Point72 Asset Management, L.P.

Q2 2026

BUY224.62 K10.38 M+22.25 K+54.8%0.01%
JC

Jpmorgan Chase & Co

Q2 2026

SELL179.00 K8.00 M+-8.54 K+36.3%0.00%
MM

Millennium Management LLC

Q2 2026

SELL27.24 K1.26 M+-760.01 K-95.2%0.00%
JH

Janus Henderson Group Plc

Q1 2026

BUY36.20 K1.20 M+18.10 K+102.8%0.00%
AC

Aqr Capital Management LLC

Q2 2026

BUY21.22 K980.01 K+9.79 K+159.0%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

BUY19.14 K884.22 K+5.97 K+102.7%0.01%
RC

Rockefeller Capital Management L.P.

Q2 2026

SELL1.73 K79.91 K+-1.19 K-17.5%0.00%